v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect of accounting change
Adjusted beginning balance
Common stock
Common stock
Adjusted beginning balance
Additional paid-in capital
Additional paid-in capital
Adjusted beginning balance
Treasury stock
Retained earnings
Retained earnings
Cumulative effect of accounting change
Retained earnings
Adjusted beginning balance
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss)
Adjusted beginning balance
Balance, beginning of year (in shares) at Dec. 31, 2022       24,920,984 24,920,984                
Balance, beginning of year at Dec. 31, 2022 $ 774,536 $ (3,808) $ 770,728 $ 2 $ 2 $ 460,720 $ 460,720 $ 0 $ 357,797 $ (3,808) $ 353,989 $ (43,983) $ (43,983)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 103,533               103,533        
Other comprehensive income 976                     976  
Share-based compensation expense, net of forfeitures 2,127         2,127              
Restricted stock activity, net of forfeitures (See Note 14 - Stockholders’ Equity) (in shares)       15,007                  
Stock option exercises (in shares)       24,648                  
Stock option exercises, net (167)         (167)              
Balance, end of year (in shares) at Dec. 31, 2023       24,960,639                  
Balance, ending of year at Dec. 31, 2023 877,197     $ 2   462,680   0 457,522     (43,007)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 75,628               75,628        
Other comprehensive income 3,895                     3,895  
Share-based compensation expense, net of forfeitures 2,375         2,375              
Issuance of common stock, net of issuance costs (in shares)       2,461,538                  
Issuance of common stock, net of issuance costs $ 79,434     $ 1   79,433              
Restricted stock activity, net of forfeitures (See Note 14 - Stockholders’ Equity) (in shares)       10,998                  
Stock option exercises (in shares) 362,430     276,504                  
Stock option exercises, net $ 2,837         2,837              
Balance, end of year (in shares) at Dec. 31, 2024 27,709,679     27,709,679                  
Balance, ending of year at Dec. 31, 2024 $ 1,041,366     $ 3   547,325   0 533,150     (39,112)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 97,936               97,936        
Other comprehensive income 11,762                     11,762  
Share-based compensation expense, net of forfeitures 3,536         3,536              
Restricted stock activity, net of forfeitures (See Note 14 - Stockholders’ Equity) (in shares)       82,415                  
Restricted stock activity, net of forfeitures (See Note 14 - Stockholders’ Equity) $ (699)         (699)              
Stock option exercises (in shares) 183,741     95,243                  
Stock option exercises, net $ (545)         (545)              
Balance, end of year (in shares) at Dec. 31, 2025 27,887,337     27,887,337                  
Balance, ending of year at Dec. 31, 2025 $ 1,153,356     $ 3   $ 549,617   $ 0 $ 631,086     $ (27,350)